BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin J, Xue B, Li X, Xia J. Monoclonal antibody therapy for neuromyelitis optica spectrum disorder: current and future. Int J Neurosci 2017;127:735-44. [PMID: 27680606 DOI: 10.1080/00207454.2016.1242587] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Gao F, Chai B, Gu C, Wu R, Dong T, Yao Y, Zhang Y. Effectiveness of rituximab in neuromyelitis optica: a meta-analysis. BMC Neurol 2019;19:36. [PMID: 30841862 DOI: 10.1186/s12883-019-1261-2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 14.0] [Reference Citation Analysis]
2 Atzeni F, Talotta R, Masala IF, Gerardi MC, Casale R, Sarzi-Puttini P. Central nervous system involvement in rheumatoid arthritis patients and the potential implications of using biological agents. Best Pract Res Clin Rheumatol 2018;32:500-10. [PMID: 31174819 DOI: 10.1016/j.berh.2019.02.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
3 Rommer PS, Hecker M, Zrzavy T, Boxberger N, Zettl UK. General Principles of Immunotherapy in Neurological Diseases. In: Mitoma H, Manto M, editors. Neuroimmune Diseases. Cham: Springer International Publishing; 2019. pp. 387-421. [DOI: 10.1007/978-3-030-19515-1_12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
4 Bruscolini A, La Cava M, Mallone F, Marcelli M, Ralli M, Sagnelli P, Greco A, Lambiase A. Controversies in the management of neuromyelitis optica spectrum disorder. Expert Review of Neurotherapeutics 2019;19:1127-33. [DOI: 10.1080/14737175.2019.1648210] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
5 Akaishi T, Nakashima I, Takahashi T, Abe M, Ishii T, Aoki M. Neuromyelitis optica spectrum disorders with unevenly clustered attack occurrence. Neurol Neuroimmunol Neuroinflamm 2020;7:e640. [PMID: 31757816 DOI: 10.1212/NXI.0000000000000640] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
6 Çakar A, Ulusoy C, Gündüz T, Küçükali Cİ, Kürtüncü M. Clinical Features of the Patients with Neuromyelitis Optica Spectrum Disorder. Noro Psikiyatr Ars 2021;58:21-5. [PMID: 33795948 DOI: 10.29399/npa.23555] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Ye S, Lin SP, Wu K, Fan Y, Xu M. Serum prealbumin is a predictive biomarker for stroke-associated infection after an ischemic stroke. Int J Neurosci 2017;127:601-5. [PMID: 27476523 DOI: 10.1080/00207454.2016.1218874] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]